Cannabis News Box

FDA issues warning letters to three CBD companies for making COVID-19 claims

FDA issues warning letters to three CBD companies for making COVID-19 claims

Bethan Rose Jenkins, Cannabis News Writer/Editorial

April 14, 2020

Three warning letters have been sent to CBD companies from the Food and Drug Administration (FDA). This is not the first time that the Agency has issued warnings to companies for making unsubstantiated health claims; 15 companies also felt the heat in November of last year. However, it is the first ti...

Clinical trials will explore the medical efficacy of Cannflavin B for pancreatic cancer

https://thetruthaboutcancer.com/characteristics-cancer-cells/

Bethan Rose Jenkins, Cannabis News Writer/Editorial

January 24, 2020

Pancreatic cancer is one of the most aggressive forms of cancer; responsible for causing an estimated 45,750 deaths in the United States alone last year. While traditional types of treatments – such as chemotherapy – may be successful in some instances, the side effects can be intolerable. Thankf...

Trump officials urged by lawmakers to lift restrictions on cannabis research

https://www.marijuana.com/wp-content/uploads/2014/05/congress.jpg

Bethan Rose Jenkins, Cannabis News Writer/Editorial

January 24, 2020

House lawmakers are becoming increasingly impatient with the federal government's prohibitionist stance on cannabis. In an attempt to lift restrictions on the plant's sale, use, possession, cultivation and research across the United States, lawmakers have prompted Trump officials to amend the rules. ...

Is medical cannabis becoming a preferred ADHD treatment over Adderall?

https://www.google.com/search?safe=active&biw=1280&bih=640&tbm=isch&sa=1&ei=hRDIXLSdHsaNlwT0279o&q=missouri+cannabis+tracking&oq=missouri+cannabis+tracking&gs_l=img.3...72311.76141..76364...0.0..1.204.1802.22j3j1......1....1..gws-wiz-img.......35i39j0i67j0j0i5i30j0i8i30j0i30j0i24.gCt3-_7-oss#imgrc=fgkFaAp_fecN-M:

Bethan Rose Jenkins, Cannabis News Writer/Editorial

January 15, 2020

More people are being diagnosed with attention deficit hyperactivity disorder (ADHD), with research demonstrating a 6.1 percent increase in diagnoses among American children between the late 1990s and 2016; according to the Centers for Disease Control and Prevention (CDC). As more cases begin to surface, so too does t...

Olivia Newton John believes medical cannabis should be on offer to everyone

Olivia Newton John believes medical cannabis should be on offer to everyone

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 29, 2019

Olivia Newton-John, star of the classic hit musical 'Grease', has been diagnosed with cancer for a third time. However, she's not letting the deadly disease dampen her spirits, with the 71-year-old praising cannabis as the treatment that has extended her life. The Australian actress recently appeared at ...

Chocolate suppresses THC levels, state researchers claim

https://www.confectionerynews.com/Article/2017/12/14/Chocolate-not-strong-marijuana-flavor-wins-edible-cannabis-consumers

Bethan Rose Jenkins, Cannabis News Writer/Editorial

September 23, 2019

Chocolate reduces THC potency, say researchers. This news will come as a shock to the many consumers who prefer to dose discreetly with cannabis edibles, such as weed-infused chocolate brownies and controlled dose chocolate bars. Perhaps one of the fastest-growing segments of the legal cannabis market in th...

Thailand adds low-level cannabis and hemp extract to its list of approved medicines

https://www.google.com/search?q=cannabis+legalization+in+thailand&safe=active&source=lnms&tbm=isch&sa=X&ved=0ahUKEwjMjd3k6OjgAhXXSRUIHYGKARAQ_AUIDygC&biw=1280&bih=689#imgrc=oITNcbIgq7t1bM:

Bethan Rose Jenkins, Cannabis News Writer/Editorial

September 15, 2019

The Kingdom of Thailand is metamorphosing from a drug-free zone to a place where patients can legally obtain extracted forms of medical cannabis. In an attempt to bolster the market that is blooming across the predominantly Buddhist Southeast Asian country, lawmakers have decided to eliminate low-level...

Study demonstrates pain-relieving efficacy of THC-rich cannabis flowers

https://www.thefire.org/schools/university-of-new-mexico/

Bethan Rose Jenkins, Cannabis News Writer/Editorial

September 11, 2019

A study recently carried out by a team of researchers from the University of New Mexico has highlighted the pain-relieving potential of cannabis' psychoactive constituent, tetrahydrocannabinol, A.K.A. 'THC'. The researchers have urged medical practitioners to pay attention to the medical benefits...

Despite legalization, the CBD and hemp industries are facing discrimination

https://hightimes.com/news/indiana-finally-legalize-cbd-oil/

Bethan Rose Jenkins, Cannabis News Writer/Editorial

August 21, 2019

The 2018 U.S. Farm Bill was expected to eliminate the uncertainty that enshrouds the hemp and CBD industries. In spite of it passing with President Donald Trump’s signature in December of last year, a great deal of discrimination still clouds the ambiguous legal CBD market. CBD (cannabidiol) is...

Curaleaf removes CBD health claims from website and social media after FDA warning

Curaleaf removes CBD health claims from website and social media after FDA warning

Bethan Rose Jenkins, Cannabis News Writer/Editorial

August 7, 2019

At the end of last month, leading medical and wellness cannabis operator Curaleaf Holdings Inc. was given a warning by the Food and Drug Administration (FDA) for making false health claims about the CBD-containing products for sale on its website. Curaleaf serves over 150,000 registered medical canna...

CEO of GW Pharma talks about Epidiolex getting FDA approval

https://globenewswire.com/news-release/2018/06/25/1529165/0/en/GW-Pharmaceuticals-plc-and-its-U-S-Subsidiary-Greenwich-Biosciences-Announce-FDA-Approval-of-EPIDIOLEX-cannabidiol-oral-solution-the-First-Plant-derived-Cannabinoid-Prescription-Me.html

Bethan Rose Jenkins, Cannabis News Writer/Editorial

July 2, 2018

On Monday, Justin Gover hit a milestone in his career. He is the CEO of GW Pharmaceuticals – a company that created a cannabis-based medicine called Epidiolex. Not only is Epidiolex being used to treat two forms of epilepsy but also, it is non-psychoactive, what with it containing the cannabis com...

Rescheduling cannabis in the States: Could the decision backfire?

https://www.bing.com/images/search?view=detailV2&ccid=l%2bAy8NMQ&id=F373403C60E81382E1F386AF8BA2DA97E0D3C834&thid=OIP.l-Ay8NMQhiu6s_P1Jhsy3wHaFj&mediaurl=https%3a%2f%2fstatic.independent.co.uk%2fs3fs-public%2fthumbnails%2fimage%2f2016%2f11%2f24%2f10%2fcannabis-1.jpg&exph=1536&expw=2048&q=cannabis&simid=608004940109843981&selectedIndex=32&ajaxhist=0

Bethan Rose Jenkins, Cannabis News Writer/Editorial

June 17, 2018

Cannabis is listed as a Schedule I narcotic, but things could be about to change. If the plant is moved to Schedule II, medical patients everywhere will rejoice. But what if the decision to reschedule cannabis in the United States backfires? There's a chance it might. If the Food and Drug Adminis...

Food and Drug Administration